- Home
- SNDL vs RLMD Comparison
SNDL vs RLMD Comparison
Compare SNDL & RLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SNDL | RLMD |
|---|---|---|
| Founded | 2006 | 2004 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Pharmaceuticals and Biotechnology | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 386.3M | 319.7M |
| IPO Year | 2019 | 2012 |
Fundamental Metrics
Financial Performance| Metric | SNDL | RLMD |
|---|---|---|
| Price | $1.57 | $6.62 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | $5.00 | ★ $10.25 |
| AVG Volume (30 Days) | ★ 897.6K | 542.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 19.21 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $13,070.00 |
| Revenue This Year | $5.48 | N/A |
| Revenue Next Year | $3.41 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 154.83 |
| 52 Week Low | $1.15 | $0.24 |
| 52 Week High | $2.89 | $5.12 |
Technical Indicators
Market Signals| Indicator | SNDL | RLMD |
|---|---|---|
| Relative Strength Index (RSI) | 53.36 | 69.19 |
| Support Level | $1.57 | $3.65 |
| Resistance Level | $1.60 | N/A |
| Average True Range (ATR) | 0.06 | 0.47 |
| MACD | 0.01 | 0.25 |
| Stochastic Oscillator | 70.85 | 76.45 |
Price Performance
Historical ComparisonAbout SNDL SNDL Inc.
SNDL Inc is a private-sector liquor and cannabis retailer in Canada with retail banners that include Ace Liquor, Wine and Beyond, Liquor Depot, Value Buds, and Spiritleaf. The principal activities of the company are the retailing of wines, beers, and spirits. It comprised four reportable segments: liquor retail, cannabis retail, cannabis operations, and investments. Liquor retail includes the sale of wines, beers, and spirits through owned liquor stores. The company generates maximum revenue from liquor retail.
About RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.